Contact us

Our latest news

Back to news >

Offering clarity to the scope of the term ‘complex medicines’

Helping innovators to develop a series of insightful, often novel characterisation techniques to understand the attributes that impact the safety and efficacy of a complex medicinal product is a key function of the Medicines Discovery Catapult.

But what would be considered within scope as a complex medicine?

Seda have worked with Medicines Discovery Catapult to offer clarity to the scope of the term ‘complex medicines’. Head over to Seda’s guest post on the  MDC blog to read the full article and associated report.